PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING

Regulatory News: Voluntis , société spécialisée dans les logiciels thérapeutiques, annonce la décision d

LEO Pharma et l’Institut Curie initient une collaboration pour identifier les facteurs de risque de survenue de thrombose chez les patients atteints de cancer. Le projet vise à évaluer dans quelle mesure l’intelligence artificielle peut compléter l’expérience du médecin pour comprendre comment certains facteurs amènent des patients atteints de cancer à développer une Maladie Thromboembolique Veineuse.

Voluntis reçoit le marquage CE pour ajouter l’insuline NPH à Insulia

BERLIN (TICpharma) - Le directeur des "solutions intégrées de santé" de Sanofi, Gilles Litman, a fait part à TICpharma des premiers résultats "prometteurs" obtenus par le laboratoire avec ses applications mobiles et dispositifs connectés pour la gestion du diabète, présentés le 22 février à Berlin lors du congrès annuel de l'Association for Advanced Technologies and Treatments for Diabetes (ATTD).

Pharmaceutiques et Techtomed organisent le 2 avril prochain le 1er évènement dédié à l’impact des nouvelles technologies au sein de l’industrie Pharmaceutiques et Techtomed organisent le 2 avril prochain Pharma HealthTech. Rencontre avec les organisateurs, Pierre Sanchez et Franck Le Meur.

VIENNE (TICpharma) - Alors que l'engouement pour la blockchain de la part des laboratoires pharmaceutiques ne fait plus aucun doute, Pascal Bouquet, directeur monde en charge de la technologie, de l’architecture et du numérique du laboratoire suisse Novartis, a jugé que la technologie "transformera le secteur pharmaceutique dans les 10 ans".

                                                                                                                                                           
Sanofi nomme Ameet Nathwani au poste de Chief Digital Officer


Le Dr Ameet Nathwani continuera d'exercer les fonctions de Vice-Président Exécutif, Chief Medical Officer




Paris - Le 12 février 2019 - Sanofi annonce la nomination du docteur Ameet Nathwani au poste de Chief Digital Officer, en complément de ses responsabilités actuelles de Vice-Président Exécutif, Chief Medical Officer.


Le Dr Nathwani aura pour mission de renforcer la stratégie de Sanofi en matière d'intégration des technologies numériques et de la science médicale, afin d'améliorer la prise en charge des patients

Husson: Over the past few years, I was lucky enough to travel to many different places: in most European countries, in the US, in Brazil, in the Middle East, in India, in Indonesia or very recently in Japan and Thailand. The digital revolution is happening all over the place and it is fascinating to see how it is changing people’s habits. In particular, mobile is a game changer in most economies and this will only accelerate. (..)

Significant economic, political, and technology trends will strain global digital strategies further by elevating the importance of local relevance. Over the next few years, we expect the following trends:

• Geopolitical shifts drive global fragmentation..
• Empowered consumers seek brands who reflect their local values (..)
• Innovative local competitors emerge (..)
• Mobile’s primacy forces a re-evaluation of local offline marketing(..)
• Rise of conversational interfaces reward local knowledge. (...)

To close this capability gap, marketers must evolve their cultural mindset, adapt their organization to share more responsibilities with local teams, implement an insights-driven approach to personalize experiences, and upgrade their global technology infrastructure.

Doctors in China are making strong use of smartphones for professional purposes, according to a new report.

The Manhattan Research Study from Decision Resources Group found that 80 per cent of physicians in the country now own or use one of the devices.

The analysts said in the topline figures they released that smartphone use covers a variety of activities and that consequently pharma marketers must tailor their approach when developing smartphone content aimed at doctors in China.

The figures put the country on a par with the US, where doctors' use of smartphones – through growing rapidly over the last few years – seems to have plateaued.

Meanwhile, the detail that Decision Resources shared from its Taking the Pulse Global 2014 report also showed that doctors in Brazil don't think pharma is making the best use of tablet detailing.

Three quarters of the doctors in Brazil surveyed said they had seen a tablet-wielding rep in 2014 but Decision Resources said satisfaction rates with the technology remains relatively low.

“Content and user-experience need to improve in order to enhance tablet-rep campaigns and increase physician satisfaction,” the analysts concluded.

Meredith Ressi, VP of marketing innovation solutions at Decision Resources, said: “Many companies now centralise digital best practices through global centers of excellence, while also giving local affiliates the flexibility to tweak their approach and asset mix to suit local market demand.

“These findings highlight the necessity of this tailored approach and can help multinational companies inform these priorities by market.”